Can granulysin provide prognostic value in primary breast cancer?
(2022)
Journal Article
Milovanović, J., Todorović-Raković, N., Vujasinović, T., Greenman, J., Mandušić, V., & Radulovic, M. (2022). Can granulysin provide prognostic value in primary breast cancer?. Pathology - Research and Practice, 237, Article 154039. https://doi.org/10.1016/j.prp.2022.154039
Background: Granulysin (GNLY) is a cytolytic and proinflammatory molecule which also acts as an immune alarmin. The multifunctional nature of this molecule has made it challenging to define its full potential as a biomarker in breast cancer. Aim: To... Read More about Can granulysin provide prognostic value in primary breast cancer?.